Project Grant HT94252410056
Award Date
4/1/24
Completion Date
3/31/27
Dollars Obligated
$720K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Chicago, IL 60612, USA
Similar Awards
The University of Illinois received a $690,539 project grant award from the Defense Health Agency through the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from August 1, 2023 through July 31, 2026 to investigate G0S2 as a master regulator of the local estrogenic environment during breast cancer progression and antiestrogen therapy. Through this award, the University will conduct scientific research that aims to transform healthcare for service...
The University of Illinois has been awarded a $1,465,443 federal Project Grant from the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420). The funding will support advanced biomedical research focused on the "Promise of Epigenetic Therapy for Refractory Testicular Germ Cell Tumors" over a 3-year period from September 1, 2025 to August 31, 2028. The Military Medical Research and Development program provides funding for innovative medical...
This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $1,602,572.00 in funding to the University of Illinois to support research on the role of the novel hexokinase HKDC1 in hepatocellular carcinoma. The award has a performance period from July 15, 2024 to July 14, 2027. The University of Illinois, a major public research university in Chicago, will conduct innovative scientific studies to advance...
The University of Illinois was awarded a $1,499,728 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on July 1, 2023, will fund research to investigate a novel approach to reverse volumetric muscle loss following transfemoral amputations, with the goal of improving mobility and function. The research aims to transform health care for service members and the American public through innovative biomedical...
This $1,599,997.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Illinois aimed at transforming healthcare for military service members, veterans, and the broader public. The research, spanning basic, applied, and translational investigations, focuses on innovative approaches to address critical health challenges across diverse medical domains such as cancer,...
This $284,659 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program will fund research at the University of Illinois to investigate the "Regeneration of the Bone Marrow Hematopoietic Niche by Jagged1-Expressing Myeloid-Derived Suppressor Cells." The research, spanning from December 1, 2024 to November 30, 2026, aims to explore innovative approaches to disease prevention, diagnosis, treatment, and...
The University of Illinois received a $237,899 Project Grant from the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct a research project titled "USING SENSORY PROCESSING TO IDENTIFY NEURAL CIRCUIT DEFICITS AND NOVEL TREATMENT STRATEGIES IN A RAT MODEL OF TSC". The research aims to transform healthcare for Service Members and the American public through innovative and impactful biomedical research. The award is for the project...
The University of Illinois was awarded a $798,912 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports research to investigate how PFAS (per- and polyfluoroalkyl substances) exposures can reprogram prostate stem cells and drive carcinogenesis and cancer progression. The 3-year project, running from July 1, 2023 to June 30, 2026, will advance scientific understanding of how environmental PFAS exposures may...
The University of Illinois was awarded a $293,978.00 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports a research project titled "COGNITION, VASCULAR FUNCTION, AND PHYSICAL ACTIVITY IN MULTIPLE SCLEROSIS" which will run from November 1, 2024 to October 31, 2026. The project aims to investigate the relationship between cognition, vascular function, and physical activity in individuals with multiple...
The Defense Health Agency awarded a $1,398,689 Project Grant to the University of Illinois under the Military Medical Research and Development program (CFDA 12.420) to support research on "Pharmacologic Downregulation of SOX2 to Enhance Efficacy of Anti-AR Therapies in Prostate Cancer". The project aims to investigate methods for improving the effectiveness of anti-androgen therapies for prostate cancer through modulating the SOX2 protein. The award will fund this 3-year research...